Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-15

Clinical Trial Update: Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating pancreatic islet cell transplantation after kidney transplantation using a novel immunosuppression approach has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Baylor Research Institute | Conditions: Islet Cell Transplantation, Type 1 Diabetes | Phase 1 | Status: WITHDRAWN